Abstract
A key component to success in structure-based drug design is reliable information on protein-ligand interactions. Recent development in NMR techniques has accelerated this process by overcoming some of the limitations of X-ray crystallography and computational protein-ligand docking. In this work we present a new scoring protocol based on NMR-derived interligand INPHARMA NOEs to guide the selection of computationally generated docking modes. We demonstrate the performance in a range of scenarios, encompassing traditionally difficult cases such as docking to homology models and ligand dependent domain rearrangements. Ambiguities associated with sparse experimental information are lifted by searching a consensus solution based on simultaneously fitting multiple ligand pairs. This study provides a previously unexplored integration between molecular modeling and experimental data, in which interligand NOEs represent the key element in the rescoring algorithm. The presented protocol should be widely applicable for protein-ligand docking also in a different context from drug design and highlights the important role of NMR-based approaches to describe intermolecular ligand-receptor interactions.
Original language | English |
---|---|
Pages (from-to) | 5819-27 |
Number of pages | 9 |
Journal | Journal of the American Chemical Society |
Volume | 135 |
Issue number | 15 |
DOIs | |
Publication status | Published - 17 Apr 2013 |
Keywords
- Animals
- Cricetinae
- Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors
- Drug Design
- Ligands
- Magnetic Resonance Spectroscopy
- Molecular Docking Simulation
- Protein Conformation
- Protein Kinase Inhibitors/metabolism